Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data

(2020) Michael Willis et al.   Diabetes Therapy

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

(2019) Vlado Perkovic et al.   NEW ENGLAND JOURNAL OF MEDICINE

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial

(2019) Kenneth W. Mahaffey et al.   CIRCULATION

Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program

(2019) Brendon L. Neuen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design

(2019) Daniel M. Sugrue et al.   PHARMACOECONOMICS

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes

(2016) Tessa Peasgood et al.   MEDICAL DECISION MAKING

EQ-5D Scores for Diabetes-Related Comorbidities

(2016) Patrick W. Sullivan et al.   VALUE IN HEALTH

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study

(2016) Mark D. Jesky et al.   PLoS One

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)

(2015) M. L. Alva et al.   DIABETIC MEDICINE

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users

(2015) P. Vemer et al.   PHARMACOECONOMICS

Utilities for treatment-related adverse events in type 2 diabetes

(2014) S. Shingler et al.   JOURNAL OF MEDICAL ECONOMICS

Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit

(2013) C. J. Hill et al.   DIABETIC MEDICINE

Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment

(2012) Agneta A Pagels et al.   Health and Quality of Life Outcomes

Conceptualizing a Model

(2012) Mark Roberts et al.   MEDICAL DECISION MAKING

Estimating the financial cost of chronic kidney disease to the NHS in England

(2012) Marion Kerr et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Notice

(2012)   Kidney International Supplements

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

(2011) Marije van der Velde et al.   KIDNEY INTERNATIONAL

When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study

(2011) J. Tattersall et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Impact of Chronic Kidney Disease on Survival After Amputation in Individuals With Diabetes

(2010) L. A. Lavery et al.   DIABETES CARE

Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death

(2010) Lorien S. Dalrymple et al.   JOURNAL OF GENERAL INTERNAL MEDICINE